BIOA
COM:BIOAGELABS
BioAge Labs
- Stock
Last Close
19.14
22/11 21:00
Market Cap
686.14M
Beta: -
Volume Today
157.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -33.22M - | -46.42M 39.75% | -37.23M 19.81% | -22.48M 39.62% | -98.15M 336.65% | -39.72M 59.53% | -63.85M 60.75% | |
depreciation and amortization | 1.71M - | 1.37M 19.84% | 4.16M 204.39% | 9.16M 120.21% | 9.35M 2.01% | 129K 98.62% | 162K 25.58% | |
deferred income tax | -76.33M - | |||||||
stock based compensation | 6.73M - | 6.95M 3.23% | 4.79M 31.06% | 3.58M 25.28% | 5.18M 44.67% | 2.54M 50.95% | 3.02M 18.74% | |
change in working capital | 76.33M - | -42.96M 156.28% | -53.03M 23.45% | 4.95M 109.34% | 17.84M 260.00% | 795K 95.54% | 6.71M 744.03% | |
accounts receivables | -158.82K - | 278.14K 275.13% | -581.07K 308.92% | -5.03K 99.14% | -3.67M 73,011.70% | |||
inventory | -521.08K - | 1.22M 334.15% | -8.05K 100.66% | -2.77M 34,278.42% | 32.37K 101.17% | |||
accounts payables | -144.37K - | 819.27K 667.47% | -983.47K 220.04% | -10.04M 920.92% | 34.88K 100.35% | 994K 2,749.61% | -393K 139.54% | |
other working capital | 824.27K - | -45.28M 5,592.82% | -51.46M 13.65% | 17.77M 134.53% | 21.44M 20.68% | 3.31M - | ||
other non cash items | -2.74M - | 58.61M 2,236.11% | 49.11M 16.22% | -32.83M 166.86% | 36.00M 209.65% | 100K 99.72% | 6.51M 6,413% | |
net cash provided by operating activities | -27.52M - | -22.45M 18.43% | -32.20M 43.41% | -37.62M 16.82% | -29.79M 20.81% | -36.18M 21.46% | -37.36M 3.26% | |
investments in property plant and equipment | -12.79M - | -103K - | -166K 61.17% | |||||
acquisitions net | ||||||||
purchases of investments | -100K - | |||||||
sales maturities of investments | ||||||||
other investing activites | -954.29K - | -88.89M 9,214.46% | -66.76M 24.90% | -421.57K 99.37% | -587.20K 39.29% | |||
net cash used for investing activites | -13.74M - | -88.89M 546.80% | -66.76M 24.90% | -421.57K 99.37% | -587.20K 39.29% | -103K 82.46% | -266K 158.25% | |
debt repayment | -792.96K - | -25M 3,052.74% | -16.06M 35.77% | -15.31M 4.65% | -19.05M 24.40% | -2.50M 86.88% | -35M 1,300% | |
common stock issued | 159.30K - | 36.25M 22,655.70% | 33.28M 8.19% | 18.48M 44.47% | 37.98M 105.52% | |||
common stock repurchased | -83.73M - | -51.04M 39.04% | -6.97M 86.34% | -16.16M 131.73% | -4.63M 71.34% | |||
dividends paid | ||||||||
other financing activites | 184.29M - | 118.45M 35.73% | 44.64M 62.31% | 60.22M 34.89% | 4.55M 92.44% | -45K 100.99% | -63K 40% | |
net cash used provided by financing activities | 99.92M - | 78.65M 21.29% | 54.89M 30.22% | 47.22M 13.96% | 18.85M 60.09% | 2.50M 86.74% | 34.94M 1,298.20% | |
effect of forex changes on cash | -954.29K - | -3.87M 305.49% | -1.96M 49.46% | 246.40K 112.60% | 224.04K 9.08% | 246K 9.80% | ||
net change in cash | 58.66M - | -32.69M 155.72% | -44.07M 34.83% | 9.19M 120.85% | -11.53M 225.49% | -33.54M 190.93% | -2.69M 91.99% | |
cash at beginning of period | 25.07M - | 83.73M 233.95% | 51.04M 39.04% | 6.97M 86.34% | 16.16M 131.73% | 61.18M 278.61% | 27.64M 54.82% | |
cash at end of period | 83.73M - | 51.04M 39.04% | 6.97M 86.34% | 16.16M 131.73% | 4.63M 71.34% | 27.64M 496.85% | 24.96M 9.72% | |
operating cash flow | -27.52M - | -22.45M 18.43% | -32.20M 43.41% | -37.62M 16.82% | -29.79M 20.81% | -36.18M 21.46% | -37.36M 3.26% | |
capital expenditure | -12.79M - | -103K - | -166K 61.17% | |||||
free cash flow | -40.31M - | -22.45M 44.30% | -32.20M 43.41% | -37.62M 16.82% | -29.79M 20.81% | -36.28M 21.80% | -37.53M 3.43% |
All numbers in (except ratios and percentages)